Ligence
1 known investors
Ligence develops Ligence Heart, an AI-based software for automated analysis and reporting of 2D transthoracic echocardiography (heart ultrasound) images. It is FDA-cleared and CE-marked, integrates with PACS and EHR systems, and is aimed at cardiologists to reduce echo reporting time.
Investors · 1
Frequently asked questions
- What does Ligence do?
- Ligence develops Ligence Heart, an AI-based software for automated analysis and reporting of 2D transthoracic echocardiography (heart ultrasound) images. It is FDA-cleared and CE-marked, integrates with PACS and EHR systems, and is aimed at cardiologists to reduce echo reporting time.
- Who are Ligence's investors?
- Ligence's investors include Coinvest Capital.